Company news
Neurocrine Biosciences, Inc. news in 2019
Neurocrine Biosciences, Inc.'s news releases, calls and decks from 2019, newest first.
Neurocrine Biosciences and Xenon Pharmaceuticals Announce Agreement to Develop First-in-Class Treatments for Epilepsy
December 1, 2019
Neurocrine Biosciences Reports Third Quarter 2019 Financial Results
November 3, 2019
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2019 Financial Results
October 13, 2019
Neurocrine Biosciences Presents New Data Analyses Demonstrating Long-Term Effects of INGREZZA® (valbenazine) 40 mg Once-Daily in Patients with Tardive Dyskinesia at the 2019 Annual Psych Congress
October 3, 2019
Neurocrine Biosciences Appoints David W. Boyer as Chief Corporate Affairs Officer
September 29, 2019
Neurocrine Biosciences to Present Data on INGREZZA® (valbenazine) for Tardive Dyskinesia; Opicapone and VY-AADC for Parkinson's Disease, at the 2019 International Congress of Parkinson's Disease and Movement Disorders®
September 16, 2019
Neurocrine Biosciences Announces Appointment of Leslie V. Norwalk to Board of Directors
September 10, 2019
Neurocrine Biosciences Reports Second Quarter 2019 Financial Results
July 28, 2019
Neurocrine Biosciences Announces FDA Acceptance of New Drug Application for Opicapone as an Adjunctive Treatment for Patients with Parkinson's Disease
July 9, 2019
Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2019 Financial Results
July 7, 2019
Neurocrine Biosciences to Present at Jefferies 2019 Global Healthcare Conference
May 29, 2019
Neurocrine Biosciences and Voyager Therapeutics Announce Phase I Results for VY-AADC in Patients with Parkinson's Disease at the American Academy of Neurology Annual Meeting
May 4, 2019
Neurocrine Biosciences Reports First Quarter 2019 Financial Results
April 28, 2019
Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2019 Financial Results
April 7, 2019
Decks in 2019
- Q3 2019 Earnings Presentation
Earnings · 34 slides · Nov 4, 2019
- Q2 2019 Earnings Presentation
Earnings · 33 slides · Jul 29, 2019